Infinity Provides Company Update and Reports Full-Year 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Infinity Pharma (INFI) Misses Q4 EPS by 8c, FY Revenue Guidance Tops Views
February 23, 2016 4:45 PM ESTInfinity Pharma (NASDAQ: INFI) reported Q4 EPS of ($0.80), $0.08 worse than the analyst estimate of ($0.72). Revenue for the quarter came in at $9 million versus the consensus estimate of $18.26 million.
GUIDANCE:
Infinity Pharma sees FY2016 revenue of $225-245 million, versus the consensus of... More
